Gravity Analytica

Leap Therapeutics to Participate at the 43rd Annual J.P. Morgan Healthcare Conference

LPTX 01.06.2025

SERA-AI Powered Highlights

Date of Upcoming Event:2025-01-15

Name of Upcoming Event:43rd Annual J.P. Morgan Healthcare Conference

Full Press Release SEC Filings Our LPTX Tweets

About Gravity Analytica

Recent Filings

CAMBRIDGE, Mass.,Jan. 6, 2025/PRNewswire/ --Leap Therapeutics, Inc.(Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced thatDouglas E. Onsi, President and Chief Executive Officer, will present a corporate overview at the 43^rdAnnualJ.P. Morgan Healthcare ConferenceinSan Francisco, CA.

Leap Presentation Details:

43^rdAnnualJ.P. Morgan Healthcare ConferenceDate:Wednesday, January 15, 2025Time:2:15 p.m. Pacific Time

A live webcast of the presentation may be accessed on the Investors page of the company's website athttps://investors.leaptx.com/, where a replay of the events will also be available for a limited time.

AboutLeap TherapeuticsLeap Therapeutics(Nasdaq: LPTX) is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein. DKN-01 is being developed in patients with esophagogastric, colorectal, and gynecological cancers. Leap's pipeline also includes FL-501, a humanized monoclonal antibody targeting the growth and differentiation factor 15 (GDF-15) protein, in preclinical development. For more information aboutLeap Therapeutics, visit http://www.leaptx.com or view our public filings with theSECthat are available via EDGAR at http://www.sec.gov or viahttps://investors.leaptx.com/.

CONTACT:

Douglas E. OnsiPresident & Chief Executive OfficerLeap Therapeutics, Inc.617-714-0360donsi@leaptx.comMatthew DeYoungInvestor RelationsArgot Partners212-600-1902leap@argotpartners.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/leap-therapeutics-to-participate-at-the-43rd-annual-jp-morgan-healthcare-conference-302336719.html

SOURCELeap Therapeutics, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com